Get the Stockscreener App
1.83
0.54%
-0.01
Shattuck Labs Inc stock is traded at $1.83, with a volume of 80,624.
It is down -0.54% in the last 24 hours and down -4.69% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$1.84
Open:
$1.9
24h Volume:
80,624
Relative Volume:
0.04
Market Cap:
$116.52M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.9482
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
-29.34%
1M Performance:
-4.69%
6M Performance:
+92.65%
1Y Performance:
+18.83%
1-Day Range:
$1.805
$1.95
1-Week Range:
$1.805
$2.705
52-Week Range:
$0.6922
$2.705
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.845 | 88.14M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Using data models to predict Shattuck Labs Inc. stock movementJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com
Automated trading signals detected on Shattuck Labs Inc.Weekly Risk Report & Fast Exit Strategy with Risk Control - newser.com
Best data tools to analyze Shattuck Labs Inc. stockJuly 2025 Technicals & Real-Time Stock Movement Alerts - newser.com
Shattuck Labs Inc. stock outlook for YEAR2025 Historical Comparison & AI Based Buy and Sell Signals - newser.com
Multi factor analysis applied to Shattuck Labs Inc.Market Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Short interest data insights for Shattuck Labs Inc.Market Growth Report & Free Long-Term Investment Growth Plans - newser.com
Multi asset correlation models including Shattuck Labs Inc.Portfolio Gains Report & Fast Gain Stock Trading Tips - newser.com
News impact scoring models applied to Shattuck Labs Inc.Oil Prices & Verified Technical Signals - newser.com
What candlestick patterns are forming on Shattuck Labs Inc.Trade Entry Report & Risk Managed Investment Strategies - newser.com
Real time social sentiment graph for Shattuck Labs Inc.Quarterly Market Summary & Daily Price Action Insights - newser.com
Shattuck Labs (NASDAQ:STTK) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Can Shattuck Labs Inc. stock deliver consistent earnings growth2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
Is Shattuck Labs Inc. stock entering bullish territoryWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
Shattuck Labs at UEG Congress: Innovative IBD Treatment Insights By Investing.com - Investing.com Canada
Shattuck Labs Hits New 52-Week High of $2.71 Amid Market Challenges - Markets Mojo
What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now? - sharewise.com
Shattuck Labs, Inc. Hits New 52-Week High at $2.64 - Markets Mojo
What recovery options are there for Shattuck Labs Inc.Earnings Risk Report & Consistent Return Strategy Ideas - newser.com
How to escape a deep drawdown in Shattuck Labs Inc.2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Chart based analysis of Shattuck Labs Inc. trendsJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - newser.com
Short Interest in Shattuck Labs, Inc. (NASDAQ:STTK) Drops By 61.0% - MarketBeat
Shattuck Labs, Inc. to Participate in Panel Discussion at UEGW Conference 2025 - Quiver Quantitative
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel - The Manila Times
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) ... - Caledonian Record
Leading IBD Expert from Mount Sinai Joins Shattuck Labs CEO for UEGW Conference Analysis Panel - Stock Titan
Oklahoma City NewsThe Oklahoman - FinancialContent
Goldman Sachs Group Inc. Decreases Stake in Shattuck Labs, Inc. $STTK - Defense World
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ashiya Mona | Director |
Aug 25 '25 |
Buy |
0.87 |
6,306,127 |
5,471,826 |
5,255,106 |
| Redmile Group, LLC | Director |
Dec 04 '24 |
Buy |
1.25 |
133,371 |
166,714 |
5,539,724 |
| Redmile Group, LLC | Director |
Dec 04 '24 |
Sale |
1.25 |
133,371 |
166,714 |
5,406,353 |
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):